Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros

Base de datos
Tipo del documento
Intervalo de año de publicación
1.
Ukr Biochem J ; 89(1): 50-8, 2017.
Artículo en Inglés | MEDLINE | ID: mdl-29236389

RESUMEN

Short-chain fatty acids (SCFAs) are major products of the microbial fermentation of dietary fiber in the colon. Recent studies suggest that these products of microbial metabolism in the gut act as signaling molecules, influence host energy homeostasis and play major immunological roles. In the present study, defined the long-term effects of ceftriaxone administration on the fecal SCFAs concentration in Wistar rats. Ceftriaxone (300 mg/kg, i.m.) was administered daily for 14 days. Rats were euthanized in 1, 15 and 56 days after ceftriaxone withdrawal. Caecal weight and fecal concentration of SCFAs by gas chromatography were measured. Ceftriaxone administration induced time-dependent rats' caecal enlargement through accumulation of undigestable substances. In 1 day after ceftriaxone withdrawal, the concentrations of acetic, propionic, butyric acids and total SCFAs were decreased 2.9-, 13.8-, 8.5-, 4.8-fold (P < 0.05), respectively. Concentration of valeric, isovaleric and caproic acids was below the detectable level. That was accompanied by decreased 4.3-fold anaerobic index and increased the relative amount of acetic acid (P < 0.05). In 56 days, concentration of SCFAs was still below control value but higher than in 1 day (except propionic acid). Anaerobic index was lower 1.3-fold (P < 0.05) vs. control. Conclusion: antibiotic therapy induced long-term disturbance in colonic microbiota metabolic activity.


Asunto(s)
Antibacterianos/farmacología , Ceftriaxona/farmacología , Colon/efectos de los fármacos , Ácidos Grasos Volátiles/metabolismo , Heces/química , Ácido Acético/metabolismo , Animales , Butiratos/metabolismo , Caproatos/metabolismo , Colon/metabolismo , Esquema de Medicación , Ácidos Grasos Volátiles/antagonistas & inhibidores , Hemiterpenos , Inyecciones Intramusculares , Masculino , Ácidos Pentanoicos/metabolismo , Propionatos/metabolismo , Ratas , Ratas Wistar , Factores de Tiempo
2.
Ukr Biochem J ; 88(6): 35-44, 2016.
Artículo en Inglés | MEDLINE | ID: mdl-29235834

RESUMEN

The epidemiological studies have shown that antibiotic treatment increases the susceptibility to inflammatory bowel disease development. The disturbance of mucus layer integrity might be one of the possible mechanisms. The aim of the present study was to investigate the effect of antibiotic ceftriaxone treatment on glycoproteins level and its carbohydrate composition in surface mucus layer of rat intestine. The study was done on male Wistar rats (140-160 g). Ceftriaxone (300 mg/kg, i.m.) was administered once a day for 14 days. The surface mucus from terminal ileum and colon were collected on the 15th, 29th and 72nd days of the experiment. Total level of mucus glycoproteins, hexoses, hexosamines, fucose and sialic acids were measured. Ceftriaxone administration did not affect the levels of glycoproteins in rat ileum. In the colon, the levels of glycoprotein were 1.3-fold decreased (Р < 0.05) on the 72nd day of the experiment. These changes were accompanied by the 1.2-fold decrease of hexoses (Р < 0.05) and 3.1-fold (Р < 0.05) decrease of fucose level and 1.5-fold (Р < 0.05) increase of the levels of sialic acids in the surface mucus of the rat colon. Thus, ceftriaxone administration induces the long-term changes in the levels of glycoproteins and carbohydrates composition in the rat colon surface mucus. This could potentially explain the susceptibility to inflammatory bowel disea­ses development.


Asunto(s)
Antibacterianos/farmacología , Ceftriaxona/farmacología , Colon/efectos de los fármacos , Íleon/efectos de los fármacos , Moco/efectos de los fármacos , Animales , Colon/química , Colon/metabolismo , Esquema de Medicación , Fucosa/metabolismo , Glicoproteínas/metabolismo , Hexosaminas/metabolismo , Hexosas/metabolismo , Íleon/química , Íleon/metabolismo , Inyecciones Intramusculares , Masculino , Moco/química , Moco/metabolismo , Ratas , Ratas Wistar , Ácidos Siálicos/metabolismo
3.
Ukr Biochem J ; 87(4): 70-7, 2015.
Artículo en Inglés | MEDLINE | ID: mdl-26547966

RESUMEN

Changes in redox status of gastric mucosa cells are the main pathogenic factor of gastric erosion and gastric ulcer development. Pro-oxidants can affect cell transcription activity via changes in redox-sensitive transcription factors. Egr-1 and Sp-1 may regulate the transcription of genes that are associated with the pathogenesis of gastric ulcer (growthfactors, cell cycle regulators, etc.). The aim of the present study was to reveal the possible involvement of zinc-finger transcriptionfactors Egr-1 & Sp-1 in the molecular mechanisms underlying gastric lesions caused by aspirin administration and stress. Gastric ulcer was induced in male rats (180-220 g) by immobilization stress combined with water-immersion (IMO-WI) or aspirin gavage (10 mg/100 g). The rats were euthanized 20 min, 1 hour, or 3 hours following the ulcerogenic factor exposure. Protein expression was determined by Western blot analysis and RT-PCR; levels of SH-groups of proteins were determined by method of Ellman et al. Development of gastric ulcer lesions was associated with twofold (P < 0.05) decrease in concentration of protein SH-groups in the rat gastric mucosa. These changes were accompanied by significant (P < 0.05) increase in the expression of Egr-1 mRNA and protein in both gastric ulcer models, and the changes in IMO-WI were more profound. Increased levels of Egr-1 were associated with the decrease in SpI protein levels. We showed for the first time the competitive interaction between redox-sensitive transcription factors Egr-1 and Sp1 in the early phases of gastric ulcer development, which might facilitate inducible transcriptional activity of Egr-1 at the expense of reduction in Sp1 activity.


Asunto(s)
Proteína 1 de la Respuesta de Crecimiento Precoz/genética , Mucosa Gástrica/metabolismo , ARN Mensajero/genética , Factor de Transcripción Sp1/genética , Úlcera Gástrica/metabolismo , Estrés Psicológico/metabolismo , Animales , Aspirina/efectos adversos , Proteína 1 de la Respuesta de Crecimiento Precoz/metabolismo , Mucosa Gástrica/patología , Regulación de la Expresión Génica , Inmovilización , Masculino , Oxidación-Reducción , ARN Mensajero/metabolismo , Ratas , Transducción de Señal , Factor de Transcripción Sp1/metabolismo , Úlcera Gástrica/etiología , Úlcera Gástrica/genética , Úlcera Gástrica/patología , Estrés Psicológico/complicaciones , Estrés Psicológico/genética , Estrés Psicológico/patología , Compuestos de Sulfhidrilo/metabolismo , Factores de Tiempo , Transcripción Genética
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA